Who We Are
ShangBay Capital is a Silicon Valley-based venture capital firm focused on investing in early stage medical device, biotech, and mobile healthcare companies.
With our unsurpassed knowledge, industry experience, and comprehensive network in the medical devices and healthcare sectors, we find and invest in high growth and disruptive startups. We partner with them by leveraging our network and expertise to create value for our portfolio companies and their investors, and deliver consistent and outstanding returns.
We give both U.S. and global investors access to best-in-class investments in medical device, biotech, and mobile healthcare companies through our deep ties with Silicon Valley and other U.S. medical hubs.
We have successfully executed great deals, helping startups quickly commercialize their products and expand their businesses. We have significant experience in deal sourcing, valuation assessment for early stage medical device companies, and evaluating the strength of a startup’s management team. We also have a deep understanding of the complex market dynamics of the medical device industry in the U.S. and globally, which is why ShangBay is uniquely capable of valuing the market potential of new companies and products. This allows us to invest in and bring the best and most disruptive products to the U.S. and global markets while delivering exceptional returns to investors.
ShangBay also has a successful record of working with various regulatory agencies to get products approved by the FDA . We leverage this experience and other resources to help our portfolio companies expedite approval and accelerate the commercialization process.